We demonstrated that MNAM can regulate liver gluconeogenesis and insulin signaling pathways in obese T2DM mice, reduce liver tissue lipid deposition, and improve insulin resistance in obese T2DM mice, resulting in reduced fasting blood glucose. This evidence concerns the gene INS and Insulin resistance.